Kings Path Partners »

Amgen shares owned by Kings Path Partners

Quarter-by-quarter ownership of Amgen (AMGN) shares owned by Kings Path Partners from 13F filings

Historical chart of Kings Path Partners investment in Amgen

Tip: Access up to 7 years of quarterly data

All positions including Amgen held by Kings Path Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amgen by Kings Path Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.4M 4.4k 322.21
2024-06-30 $1.4M 4.4k 312.45

More positions owned by Kings Path Partners

Vanguard Index Fds Total Stk Mkt (VTI)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Schwab Strategic Tr Us Tips Etf (SCHP)

View all positions for Kings Path Partners

Top funds holding Amgen

Vanguard Group
BlackRock
State Street Corporation
Morgan Stanley
PRIMECAP Management Company
Geode Capital Management
Charles Schwab Investment Management
Wells Fargo & Company
Bank of America Corporation
Goldman Sachs Group
Bank of New York Mellon
Royal Bank of Canada
Henderson Group
T. Rowe Price Associates
Reed Conner & Birdwell

View all funds holding Amgen